financing
Forendo Pharma raises additional funding to accelerate development of women’s health portfolio
Clinical stage drug development company, Forendo Pharma, has raised an additional €4 million of funding from Vesalius Biocapital III Partners, which will be used with other raised funds to accelerate the development of its women’s health portfolio. Read more
Emulate secures millions in latest financing round to expand product portfolio
Privately held company, Emulate, has secured a $36 million Series C financing round, the funds from which will be used to expand the company’s product suite and commercialisation of its Human Emulation System. Read more
The top five tweets: From financing to big data — what did EPM readers enjoy reading this week?
Here we count down the top five tweets from @EPM_magazine that have gained the most impressions this week, taken from Twitter analytics. Read more
UK biotech raises £6.9 million in series A financing round
UK-based biotech, Orbit Discovery, has closed its series A financing round, raising £6.9 million, which will enable the company to expand its platform and achieve milestones in current partnerships. Read more
The top five tweets: From antibiotics to biotech — what rated top with EPM readers this week?
Here we count down the top five tweets from @EPM_magazine that have gained the most impressions this week, taken from Twitter analytics. Read more
Mimetas secures $20.5 million in financing round
Mimetas, provider of organ-on-a-chip technologies and tissue models, has secured $20.5 million in financing from an international syndicate from Asia and Europe. Read more
Biotech financing update shows a solid start to the year for the sector
The BIA and business intelligence group, Informa, have released their first quarterly financing update on the biotech sector, showing that venture capital financing and follow on financings on the public markets are off to a solid start Read more
Liverpool based chemical intermediates company raises £1.5 million
The specialist Liverpool based chemical intermediates company, Liverpool Chirochem (LCC), has raised £1.5 million in equity finance to support growth plans and increase production capacity overseas. Read more
Biotech completes financing round to advance neuromuscular treatments
A financing round worth €38 million has been completed by biotech company, NMD Pharma, to advance the treatments of neuromuscular disorders. Read more
Cassini closes series A financing round
Cassini, developer of corneal diagnostic solutions, has successfully closed a series A financing round with venture capital fund Innovation Industries. Read more
Evonetix completes financing round to advance its technology
Cambridge-based company, Evonetix, has completed a series A financing round, raising $12.3 million to be used in the advancement of its novel gene synthesis platform. Read more
Biotech raises $58 million in funding to advance drug programmes
Pandion Therapeutics, a biotechnology company, has raised $58 million at the completion of its Series A financing round, which will be used to advance its initial drug programmes for autoimmune and inflammatory diseases Read more
Biotech company closes financing round worth $47 million
Biotech company Scholar Rock has closed a $47 million Series C financing round, which will be used to advance its innovative pipeline for spinal muscular atrophy (SMA), immune-oncology, fibrosis and iron-restricted anaemias. Read more
Funds raised by Discngine for advancement of its SaaS solution
Software company that specialises in applications for life sciences research, Discngine, has raised €1.1 million in a Series A financing round, allowing the company to move forward with its Software-as-a-Service (SaaS) solution. Read more
Dutch biotech secures funds to develop novel treatment for NASH
NorthSea Therapeutics, a Dutch biotech company, has secured €25 million in a Series A funding round, which will be used for the development of icosabutate — a SEFA as a novel, oral approach for the treatment of NASH Read more
Series A financing will speed up development of therapies for drug-resistant infections
Biopharmaceutical company, Antabio, has completed a €7.3 million series A financing round for the development of novel therapies to treat drug-resistant gram-negative infections. Read more
Bonus! The value of new-generation digitalised technology in pharma
Chris Wilkinson, head of sales for Healthcare for Siemens Financial Services in the UK, looks at the value of new-generation digitalised technology within the pharmaceutical industry. Read more
Flexibly financing: Keeping up with technology advances doesn’t have to be overly costly
Chris Wilkinson, head of sales for Healthcare and Public Sector for Siemens Financial Services, UK, writes about the importance for pharma to keep up with technological advancements and how flexible financing can help. Read more
Polyphor closes private financing round
Clinical-stage Swiss speciality pharma company, Polyphor, has announced the completion of a CHF40 million private placement. The majority of the financing (98%) was provided by existing investors. Read more
Thermo Fisher buys Affymetrix for £898m
Thermo Fisher Scientific has bought Affymetrix, a provider of cellular and genetic analysis products for £898m ($1.3bn) Read more
